Prognostic value of cytokines in SIRS general medical patients

被引:81
作者
Rodríguez-Gaspar, M
Santolaria, F [1 ]
Jarque-López, A
González-Reimers, E
Milena, A
de la Vega, MJ
Rodríguez-Rodríguez, E
Gómez-Sirvent, JL
机构
[1] Univ La Laguna, Hosp Univ Canarias, Med Interna Serv, Tenerife, Spain
[2] Univ La Laguna, Hosp Univ Canarias, Lab Serv, Tenerife, Spain
关键词
D O I
10.1006/cyto.2001.0932
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We studied 174 patients with SIRS criteria, 45 with sepsis, eight with severe sepsis and 13 with septic shock. Serum TNF-alpha, IL-6, IL-8 and IL-10 levels were raised in SIRS patients, even in those cases in which an infection could not be documented, and more intensely in severe sepsis and in patients who died (11%). The slope of the regression line between IL-10 and TNF-alpha was sharper in patients with severe sepsis and in those who died; an imbalance between pro- and anti-inflammatory cytokines may be related to poor prognosis. Increased IL-6 and IL-10, decreased muscle mass, raised BUN and low body temperature were all independently related to prognosis. (C) 2001 Academic Press.
引用
收藏
页码:232 / 236
页数:5
相关论文
共 15 条
[1]   Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock [J].
Arnalich, F ;
López, J ;
Codoceo, R ;
Jiménez, M ;
Madero, R ;
Montiel, C .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03) :908-911
[2]   TOWARD AN EPIDEMIOLOGY AND NATURAL-HISTORY OF SIRS (SYSTEMIC INFLAMMATORY RESPONSE SYNDROME) [J].
BONE, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (24) :3452-3455
[3]   HYPOTHERMIA IN THE SEPSIS SYNDROME AND CLINICAL OUTCOME [J].
CLEMMER, TP ;
METZ, CA ;
GORIS, GB ;
HEARRON, MS ;
SHEAGREN, JN ;
BONE, RC ;
BALK, RA ;
FISHER, CJ ;
ALBERTSON, TE ;
FOULKE, GE ;
MONDRAGON, NK ;
CLEMMER, TP ;
SMITH, JL ;
NYMAN, K ;
SLOTMAN, GJ ;
BURCHARD, KW ;
DAREZZO, A ;
MCLEES, BD ;
MCCALL, CE ;
ALFORD, P ;
JASTREMSKI, MS ;
CHELLURI, L ;
PURI, VK ;
KRUSE, J ;
BOYES, R ;
BANDER, JJ ;
ELLRODT, AG ;
ZELUFF, BJ ;
GENTRY, LO ;
MARTIN, RR ;
SABA, HI ;
BREEN, JF ;
LEIBOWITZ, AI ;
BLACKWOOD, JM ;
MACHIEDO, GW ;
SOTOGREEN, M ;
PLOUFFE, JF ;
SANDERS, CV ;
LYNNBESCH, C ;
DERKS, FW ;
VENEZIO, FR ;
CAPLAN, ES ;
BELZBERG, H ;
DELAPORTAS, D ;
CERRA, FB ;
MANN, HJ ;
PHAIR, JP ;
DAVISON, R ;
THOMAS, FO ;
GOLDSMITH, J .
CRITICAL CARE MEDICINE, 1992, 20 (10) :1395-1401
[4]   Sepsis and serum cytokine concentrations [J].
Damas, P ;
Canivet, JL ;
DeGroote, D ;
Vrindts, Y ;
Albert, A ;
Franchimont, P ;
Lamy, M .
CRITICAL CARE MEDICINE, 1997, 25 (03) :405-412
[5]   Plasma proinflammatory cytokine concentrations, acute physiology and chronic health evaluation (APACHE) III scores and survival in patients in an intensive care unit [J].
Friedland, JS ;
Porter, JC ;
Daryanani, S ;
Bland, JM ;
Screaton, NJ ;
Vesely, MJJ ;
Griffin, GE ;
Bennett, ED ;
Remick, DG .
CRITICAL CARE MEDICINE, 1996, 24 (11) :1775-1781
[6]   Blood interleukin 10 levels parallel the severity of septic shock [J].
Friedman, G ;
Jankowski, S ;
Marchant, A ;
Goldman, M ;
Kahn, RJ ;
Vincent, JL .
JOURNAL OF CRITICAL CARE, 1997, 12 (04) :183-187
[7]   Circulating interleukin 6 and interleukin 10 in community acquired pneumonia [J].
Glynn, P ;
Coakley, R ;
Kilgallen, I ;
Murphy, N ;
O'Neill, S .
THORAX, 1999, 54 (01) :51-55
[8]   Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options [J].
Gogos, CA ;
Drosou, E ;
Bassaris, HP ;
Skoutelis, A .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :176-180
[9]   Hypothermia enhances the biological activity of lipopolysaccharide by altering its fluidity state [J].
Luhm, J ;
Schromm, AB ;
Seydel, U ;
Brandenburg, K ;
Wellinghausen, N ;
Riedel, E ;
Schumann, RR ;
Rink, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 256 (02) :325-333
[10]   Bedside prediction of mortality from bacteremic sepsis - A dynamic analysis of ICU patients [J].
Pittet, D ;
Thievent, B ;
Wenzel, RP ;
Li, N ;
Auckenthaler, R ;
Suter, PM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (02) :684-693